242 related articles for article (PubMed ID: 23925386)
1. Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment.
Llàcer P; Bayés-Genís A; Núñez J
Med Clin (Barc); 2019 Apr; 152(7):266-273. PubMed ID: 30442374
[TBL] [Abstract][Full Text] [Related]
3. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J; de la Espriella R; Miñana G; Santas E; Llácer P; Núñez E; Palau P; Bodí V; Chorro FJ; Sanchis J; Lupón J; Bayés-Genís A
Eur J Heart Fail; 2021 Sep; 23(9):1445-1457. PubMed ID: 34241936
[TBL] [Abstract][Full Text] [Related]
4. CA125: An Increasingly Promising Biomarker of Heart Failure.
Pan C; Zhou M; Jian Y; Zeng Y; Wang M; Chen F
Curr Pharm Des; 2021; 27(37):3871-3880. PubMed ID: 33461452
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
6. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
9. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen 125: a new biomarker in heart failure.
Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
[TBL] [Abstract][Full Text] [Related]
11. Value of BNP and tumour marker CA125 in patients with heart failure.
Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
15. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
[TBL] [Abstract][Full Text] [Related]
17. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
18. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
[TBL] [Abstract][Full Text] [Related]
19. Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies.
Zhuang J; Faggiano P; Li Q; Pradelli D; Med V; Peng W; Zuo M; Xu Y
J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):864-72. PubMed ID: 25353973
[TBL] [Abstract][Full Text] [Related]
20. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
